U.S. Electronic Equipment and Components Stock News

NasdaqGM:GHRS
NasdaqGM:GHRSPharmaceuticals

Assessing GH Research (GHRS) Valuation After New Shelf Registration And Follow On Equity Plan

Capital raising moves put GH Research in focus GH Research (GHRS) has filed a universal shelf registration of up to US$400 million across multiple securities, alongside a US$200 million at-the-market follow-on equity program for its ordinary shares. See our latest analysis for GH Research. The capital raising plans come after a strong run, with the share price at US$21.88 and a 30 day share price return of 33.9%. The 1 year total shareholder return of 119.24% and 3 year total shareholder...
NasdaqGM:IRMD
NasdaqGM:IRMDMedical Equipment

A Look At IRADIMED (IRMD) Valuation After Strong Q1 Results Dividend And Reaffirmed Guidance

What IRADIMED’s latest dividend and guidance mean for shareholders IRADIMED (IRMD) has drawn fresh attention after reporting first quarter results, reaffirming its 2026 earnings outlook, and declaring a regular quarterly dividend of $0.20 per share payable on May 29, 2026. See our latest analysis for IRADIMED. IRADIMED’s latest results and dividend decision have arrived as the share price has eased in recent months, with a 30 day share price return of 7.13% down and a 90 day return of 12.94%...
NasdaqGS:MXCT
NasdaqGS:MXCTLife Sciences

MaxCyte (MXCT) EPS Loss Narrows In Q1 2026 Challenging Bearish Profitability Narratives

MaxCyte (NasdaqGS:MXCT) opened Q1 2026 with revenue of US$9.7 million and a basic EPS loss of US$0.04, while trailing 12 month figures show revenue of US$32.3 million and a basic EPS loss of US$0.37. The company has seen quarterly revenue move from US$10.4 million in Q1 2025 to US$9.7 million in Q1 2026, with net income moving from a loss of US$10.3 million to a loss of US$4.8 million over the same period. These figures frame the discussion for investors who are focused on how margins develop...
NYSE:S
NYSE:SSoftware

SentinelOne (S) Valuation Check After Wayfinder Frontier AI Launch And Ongoing Profitability Concerns

SentinelOne (S) is back in focus after launching its Wayfinder Frontier AI Services, even as investors weigh this product expansion against ongoing concerns about margins, profitability, and tough competition from CrowdStrike. See our latest analysis for SentinelOne. At a share price of $16.51, SentinelOne has seen a 29.49% 30 day share price return and a 19.03% 90 day share price return, yet the 1 year total shareholder return is down 17.94%. This suggests recent momentum has picked up even...
NYSE:CMDB
NYSE:CMDBShipping

Costamare Bulkers Holdings (CMDB) Q1 Profitability Challenges Longstanding Bearish Earnings Narratives

Costamare Bulkers Holdings (NYSE:CMDB) has opened 2026 with Q1 revenue of US$111.5 million, basic EPS of US$0.41 and net income of US$9.9 million, setting a clearer profit picture against a share price of US$19.02. The company has previously reported quarterly revenue figures ranging from US$222.9 million to US$318.9 million and a mix of positive and loss making EPS and net income results, so this quarter slots into a track record that already includes periods of pressure on earnings quality...
NasdaqGS:HWKN
NasdaqGS:HWKNChemicals

Hawkins (HWKN) Margin Compression Challenges Bullish Community Narratives

Hawkins (HWKN) has wrapped up FY 2026 with fourth quarter revenue of US$265.9 million and basic EPS of US$0.75, rounding out a trailing twelve month run of US$1.08 billion in revenue and EPS of US$3.93. Over the past six quarters, revenue has moved from US$245.3 million in Q4 FY 2025 to US$265.9 million in Q4 FY 2026, while quarterly EPS has ranged between US$0.69 and US$1.41. This gives investors a clear view of how the top line and per share earnings have tracked into the latest print. With...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Profitable AI Stocks One Debt Free Earner One Quiet Chip Powerhouse

AI spending is no longer just a race to build the biggest models; it is increasingly about which companies can turn that investment into real earnings. With inflation pressures touching everything from fuel to freight, and central banks keeping rates higher for longer, cash generation and pricing power matter more than ever. The Profitable AI Stocks screener focuses on businesses already using AI to support profits rather than just promises. This article highlights 3 stocks from that list...
NYSE:CF
NYSE:CFChemicals

Is It Too Late To Reassess CF Industries (CF) After Its Strong 2025 Rally?

If you are wondering whether CF Industries Holdings at US$122.97 is still offering value after its run, the next sections walk through what the current price may be baking in. The stock has returned 3.6% over the last 7 days, 3.4% over the past month, 53.5% year to date and 45.1% over the last year, so recent performance is front of mind for many investors assessing what comes next. Recent news coverage has focused on CF Industries Holdings as a key player in the fertilizers and chemicals...
NYSE:CTRE
NYSE:CTREHealth Care REITs

Assessing CareTrust REIT (CTRE) Valuation After Raised 2026 Guidance And Strong First Quarter Results

CareTrust REIT (CTRE) raised its 2026 earnings guidance and shared first quarter results that showed higher revenue and net income, giving investors fresh data on how the healthcare focused landlord is currently performing. See our latest analysis for CareTrust REIT. The stock has gained 15.48% year to date on a share price basis to $41.93, while the 1 year total shareholder return of 52.47% and 3 year total shareholder return above 7x suggest momentum has been strong over multiple...
NYSE:HPE
NYSE:HPETech

Hewlett Packard Enterprise (HPE) Valuation Check As New AI Cloud And Server Launches Draw Investor Attention

Hewlett Packard Enterprise (HPE) has just rolled out new GreenLake private cloud and storage updates alongside the HPE Compute Scale-up Server 3250, highlighting AI focused infrastructure that is drawing fresh attention to the stock. See our latest analysis for Hewlett Packard Enterprise. Those AI focused GreenLake and server launches arrive as momentum in Hewlett Packard Enterprise’s stock has picked up, with the share price delivering a 39.5% 30 day return and a 98.6% 1 year total...
NYSE:ED
NYSE:EDIntegrated Utilities

Is Consolidated Edison (ED) Fairly Priced After Recent Power Grid Infrastructure Focus

If you are wondering whether Consolidated Edison at around US$107 per share still offers fair value, you will want to see how different valuation methods line up on this stock. The share price has moved 0.7% over the last week, is down 4.1% over the last month, yet shows returns of 7.1% year to date, 8.5% over 1 year, 24.5% over 3 years and 62.7% over 5 years. This gives useful context before comparing price to fundamentals. Recent headlines have focused on Consolidated Edison in relation to...
NYSE:HUBB
NYSE:HUBBElectrical

Assessing Hubbell (HUBB) Valuation After Recent Share Price Pullback And Conflicting Fair Value Signals

Recent share performance and business scale Hubbell (HUBB) has drawn attention after the stock fell about 12% over the past month and about 8% over the past 3 months, prompting investors to reassess its recent run and current fundamentals. The company, headquartered in Shelton, Connecticut, reports annual revenue of US$5.996b and net income of US$904.3m. Its operations are split between its Utility Solutions and Electrical Solutions segments, with most revenue generated in the United...
NYSE:PL
NYSE:PLProfessional Services

Planet Labs Czech Deal Highlights Growing European AI Agriculture Footprint

Planet Labs PBC (NYSE:PL), through its German subsidiary, has secured a significant two-year contract with the Czech Republic's State Agricultural Intervention Fund. The agreement covers satellite imagery and AI-powered analytics to support agricultural monitoring and payments across the country. The contract is a multi-year, seven-figure national government deal that expands Planet Labs' role with European public sector agencies. Planet Labs PBC operates a fleet of Earth observation...
NasdaqGS:COST
NasdaqGS:COSTConsumer Retailing

Assessing Whether Costco Wholesale (COST) Shares Look Overvalued After Strong Multi‑Year Returns

How Costco Wholesale (COST) Stock Has Been Performing Costco Wholesale (COST) has caught investor attention after recent trading, with the stock last closing at US$1,041.25 and showing mixed short and longer term total returns across different time frames. See our latest analysis for Costco Wholesale. The recent 1-month share price return of 6.82% and year to date share price return of 21.85%, alongside a 5-year total shareholder return of 186.53%, indicate that momentum has been building...
NasdaqGS:PFG
NasdaqGS:PFGInsurance

Is Principal (PFG) Using Benefits Tech Integrations to Sharpen Its Competitive Edge in Group Insurance?

In May 2026, Principal Financial Group announced a new API integration with benefits administration platform Employee Navigator, allowing employees to complete evidence of insurability health questions directly within their initial benefits enrollment to streamline data sharing and speed up underwriting decisions for group benefits. This move highlights Principal’s push to simplify benefits administration for more than 90,000 small and midsize employer clients by reducing enrollment...
NYSE:ORCL
NYSE:ORCLSoftware

Oracle Taps Cleveland Clinic Chief To Deepen Healthcare And AI Focus

Oracle (NYSE:ORCL) has appointed Cleveland Clinic CEO Dr. Tomislav Mihaljevic to its Board of Directors. The appointment connects Oracle more closely with a leading global healthcare provider as the company focuses on health and life sciences. This move comes as Oracle expands healthcare data, cloud, and AI-enabled medical solutions, including its work around Cerner and recent health sector partnerships. For investors tracking Oracle, the appointment highlights how seriously the company is...
NYSE:JNJ
NYSE:JNJPharmaceuticals

How Investors Are Reacting To Johnson & Johnson (JNJ) Expanding Its Coronary Lithotripsy Device Portfolio

Earlier this week, Johnson & Johnson’s Shockwave Medical unit launched the Shockwave C2 Aero coronary intravascular lithotripsy catheter globally, offering improved deliverability, lesion crossing and repositioning for treating calcified coronary artery disease in the U.S. and Japan, with Europe and Canada to follow. This next-generation device broadens Johnson & Johnson’s intravascular lithotripsy portfolio in a complex, high-need area of cardiovascular care, reinforcing the company’s...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

Did Nurix’s (NRIX) EHA Oral BTK Degrader Data Just Reframe Its Oncology Investment Narrative?

Nurix Therapeutics announced that CEO Arthur T. Sands will join fireside chats at major upcoming healthcare conferences and that updated efficacy and safety data for its oral BTK degrader bexobrutideg (NX-5948) in chronic lymphocytic leukemia will be presented in an oral session at the 2026 European Hematology Association Congress. The oral presentation slot and conference participation highlight growing scientific and investor attention on Nurix’s targeted protein degradation pipeline,...
NasdaqGM:CAMT
NasdaqGM:CAMTSemiconductor

Camtek (CAMT) Q1 2026 EPS Reset Tests Bullish AI Margin Narratives

Camtek (NasdaqGM:CAMT) sets the tone with Q1 2026 earnings Camtek (NasdaqGM:CAMT) opened 2026 with Q1 revenue of US$121.7 million and basic EPS of US$0.68, setting a clear marker for how the year is starting to shape up. The company has seen revenue move from US$117.3 million in Q4 2024 to US$128.1 million in Q4 2025, with basic EPS across those periods ranging from US$0.73 to US$0.78, while trailing 12 month EPS sits at US$1.05 on revenue of US$499.1 million. With a trailing net margin of...
NasdaqGS:MQ
NasdaqGS:MQDiversified Financial

3 Elite Penny Stocks With Strength To Withstand Higher Rates

Rising inflation worries, higher bond yields and choppy energy markets are putting pressure on weaker companies, especially those that rely heavily on cheap financing to survive. That environment can be harsh for most penny stocks, which often run out of cash before their plans get off the ground. The Elite Penny Stocks screener focuses only on companies with balance sheets that look better equipped to fund their ambitions. In this article, you will see 3 of the most interesting stocks from...
NYSE:NET
NYSE:NETIT

Cloudflare (NET) Is Down 22.2% After 20% Layoffs To Fund AI Pivot Is The Bull Case Changed?

In early May 2026, Cloudflare announced a plan to cut about 20% of its workforce and incur roughly US$140 million to US$150 million in restructuring charges as it reorients the business around an agentic AI-first operating model, alongside reporting first-quarter 2026 revenue of US$639.76 million and a narrower net loss of US$22.93 million. At the same time, Cloudflare issued second-quarter and full-year 2026 revenue guidance and framed the workforce reductions as an operational reset to...
NasdaqGS:TRIN
NasdaqGS:TRINCapital Markets

Assessing Trinity Capital (TRIN) Valuation After New US$300 Million Equity Offering And Recent Earnings

Why Trinity Capital's fresh equity raise matters after earnings Trinity Capital (TRIN) has followed its recent first quarter earnings release with a new at the market follow on equity offering of up to US$300 million in common stock. The timing links two key themes investors tend to focus on: quarterly profitability and balance sheet capacity. It also raises fresh questions about how the company might deploy additional capital against its existing tech lending and equipment financing...
NYSE:OKLO
NYSE:OKLOElectric Utilities

Assessing Oklo (OKLO) Valuation After Regulatory Milestone And New AI Partnership

Rising interest in Oklo (OKLO) is being driven by a cluster of fresh updates, including wider first quarter losses, a sizeable cash position, accelerated U.S. regulatory progress, and a new AI focused partnership with Idaho National Laboratory. See our latest analysis for Oklo. Oklo’s share price has pulled back in the very short term, with a 1 day share price return down 3.52% and a 7 day share price return down 6.43%, even after a 14.73% 30 day share price return and a very large 3 year...
NasdaqCM:PAYS
NasdaqCM:PAYSDiversified Financial

Is Paysign’s (PAYS) Affordability Shift Redefining Its Core Profit Engine?

Paysign, Inc. reported past first-quarter 2026 results on May 12, posting revenue of US$28.04 million and net income of US$5.44 million, with diluted EPS of US$0.09 from continuing operations. The quarter marked a shift as patient affordability programs became Paysign’s largest revenue contributor, reflecting a mix change toward higher-margin pharma offerings. We’ll now examine how this record first quarter and the rise of patient affordability as Paysign’s largest revenue stream affect its...